Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1985 Oct;143(4):503–507.

Primary hepatocellular carcinoma--recent advances and future prospects.

PMCID: PMC1306378  PMID: 3004044

Full text

PDF
503

Images in this article

504Figure 1.
on p.504
504Figure 2.
on p.504

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beasley R. P., Hwang L. Y., Lin C. C., Chien C. S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981 Nov 21;2(8256):1129–1133. doi: 10.1016/s0140-6736(81)90585-7. [DOI] [PubMed] [Google Scholar]
  2. Berg N. O., Eriksson S. Liver disease in adults with alpha-1 -antitrypsin deficiency. N Engl J Med. 1972 Dec 21;287(25):1264–1267. doi: 10.1056/NEJM197212212872502. [DOI] [PubMed] [Google Scholar]
  3. Blumberg B. S., London W. T. Hepatitis B virus and the prevention of primary hepatocellular carcinoma. N Engl J Med. 1981 Mar 26;304(13):782–784. doi: 10.1056/NEJM198103263041312. [DOI] [PubMed] [Google Scholar]
  4. Bréchot C., Degos F., Lugassy C., Thiers V., Zafrani S., Franco D., Bismuth H., Trépo C., Benhamou J. P., Wands J. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med. 1985 Jan 31;312(5):270–276. doi: 10.1056/NEJM198501313120503. [DOI] [PubMed] [Google Scholar]
  5. Buchwald H., Grage T. B., Vassilopoulos P. P., Rohde T. D., Varco R. L., Blackshear P. J. Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer. 1980 Mar 1;45(5):866–869. doi: 10.1002/1097-0142(19800301)45:5<866::aid-cncr2820450507>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  6. Cady B. Natural history of primary and secondary tumors of the liver. Semin Oncol. 1983 Jun;10(2):127–134. [PubMed] [Google Scholar]
  7. Cady B., Oberfield R. A. Arterial infusion chemotherapy of hepatoma. Surg Gynecol Obstet. 1974 Mar;138(3):381–384. [PubMed] [Google Scholar]
  8. Campbell T. C., Hayes J. R. The role of aflatoxin metabolism in its toxic lesion. Toxicol Appl Pharmacol. 1976 Feb;35(2):199–222. doi: 10.1016/0041-008x(76)90282-9. [DOI] [PubMed] [Google Scholar]
  9. Chlebowski R. T., Tong M., Weissman J., Block J. B., Ramming K. P., Weiner J. M., Bateman J. R., Chlebowski J. S. Hepatocellular carcinoma. Diagnostic and prognostic features in North American patients. Cancer. 1984 Jun 15;53(12):2701–2706. doi: 10.1002/1097-0142(19840615)53:12<2701::aid-cncr2820531224>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  10. Craig J. R., Peters R. L., Edmondson H. A., Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer. 1980 Jul 15;46(2):372–379. doi: 10.1002/1097-0142(19800715)46:2<372::aid-cncr2820460227>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  11. Davis H. L., Jr, Ramirez G., Ansfield F. J. Adenocarcinomas of stomach, pancreas, liver, and biliary tracts. Survival of 328 patients treated with fluoropyrimidine therapy. Cancer. 1974 Jan;33(1):193–197. doi: 10.1002/1097-0142(197401)33:1<193::aid-cncr2820330128>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  12. Ensminger W. D., Gyves J. W. Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol. 1983 Jun;10(2):176–182. [PubMed] [Google Scholar]
  13. Ensminger W. D., Rosowsky A., Raso V., Levin D. C., Glode M., Come S., Steele G., Frei E., 3rd A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Res. 1978 Nov;38(11 Pt 1):3784–3792. [PubMed] [Google Scholar]
  14. Enwonwu C. O. The role of dietary aflatoxin in the genesis of hepatocellular cancer in developing countries. Lancet. 1984 Oct 27;2(8409):956–958. doi: 10.1016/s0140-6736(84)91168-1. [DOI] [PubMed] [Google Scholar]
  15. Ettinger D. S., Dragon L. H., Klein J., Sgagias M., Order S. E. Isotopic immunoglobulin in an integrated multimodal treatment program for a primary liver cancer: a case report. Cancer Treat Rep. 1979 Jan;63(1):131–134. [PubMed] [Google Scholar]
  16. Falkson G., Moertel C. G., Lavin P., Pretorius F. J., Carbone P. P. Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial. Cancer. 1978 Nov;42(5):2149–2156. doi: 10.1002/1097-0142(197811)42:5<2149::aid-cncr2820420510>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  17. Friedman M. A., Demanes D. J., Hoffman P. G., Jr Hepatomas: hormone receptors and therapy. Am J Med. 1982 Sep;73(3):362–366. [PubMed] [Google Scholar]
  18. Friedman M. A., Volberding P. A., Cassidy M. J., Resser K. J., Wasserman T. H., Phillips T. L. Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1885–1888. [PubMed] [Google Scholar]
  19. Garnick M. B., Ensminger W. D., Israel M. A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin. Cancer Res. 1979 Oct;39(10):4105–4110. [PubMed] [Google Scholar]
  20. Ihde D. C., Sherlock P., Winawer S. J., Fortner J. G. Clinical manifestations of hepatoma. A review of 6 years' experience at a cancer hospital. Am J Med. 1974 Jan;56(1):83–91. doi: 10.1016/0002-9343(74)90753-0. [DOI] [PubMed] [Google Scholar]
  21. Iwatsuki S., Shaw B. W., Jr, Starzl T. E. Experience with 150 liver resections. Ann Surg. 1983 Mar;197(3):247–253. doi: 10.1097/00000658-198303000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology. 1977 Aug;73(2):386–394. [PubMed] [Google Scholar]
  23. Locker G. Y., Doroshow J. H., Zwelling L. A., Chabner B. A. The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine (Baltimore) 1979 Jan;58(1):48–64. doi: 10.1097/00005792-197901000-00003. [DOI] [PubMed] [Google Scholar]
  24. Manns M., Meyer zum Büschenfelde K. H. A mitochondrial antigen-antibody system in cholestatic liver disease detected by radioimmunoassay. Hepatology. 1982 Jan-Feb;2(1):1–7. doi: 10.1002/hep.1840020102. [DOI] [PubMed] [Google Scholar]
  25. McIntire K. R., Vogel C. L., Primack A., Waldmann T. A., Kyalwazi S. K. Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma. Cancer. 1976 Feb;37(2):677–683. doi: 10.1002/1097-0142(197602)37:2<677::aid-cncr2820370211>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  26. Mittal R., Kowal C., Starzl T., Van Thiel D., Bron K., Iwatsuki S., Schade R., Straub W., Dekker A. Accuracy of computerized tomography in determining hepatic tumor size in patients receiving liver transplantation or resection. J Clin Oncol. 1984 Jun;2(6):637–642. doi: 10.1200/JCO.1984.2.6.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Moriarty A. M., Alexander H., Lerner R. A., Thornton G. B. Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. Science. 1985 Jan 25;227(4685):429–433. doi: 10.1126/science.2981434. [DOI] [PubMed] [Google Scholar]
  28. Nolan T. R., Grady E. D., Crumbley A. J., Larose J. H., Cheek W. V. Internal hepatic radiotherapy: I. Organ distribution of colloidal Cr32 PO4 injected into a peripheral vein, the portal vein, or the arterial supply of the gastrointestinal tract in the rat. Am J Roentgenol Radium Ther Nucl Med. 1975 Aug;124(4):590–595. doi: 10.2214/ajr.124.4.590. [DOI] [PubMed] [Google Scholar]
  29. Olweny C. L., Katongole-Mbidde E., Bahendeka S., Otim D., Mugerwa J., Kyalwazi S. K. Further experience in treating patients with hepatocellular carcinoma in Uganda. Cancer. 1980 Dec 15;46(12):2717–2722. doi: 10.1002/1097-0142(19801215)46:12<2717::aid-cncr2820461230>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  30. Pettavel J., Morgenthaler F. Protracted arterial chemotherapy of liver tumors: an experience of 107 cases over a 12-year period. Prog Clin Cancer. 1978;7:217–233. [PubMed] [Google Scholar]
  31. Prevention of primary liver cancer. Report on a meeting of a W.H.O. Scientific Group. Lancet. 1983 Feb 26;1(8322):463–465. [PubMed] [Google Scholar]
  32. Sakurai M., Okamura J., Kuroda C. Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study. Cancer. 1984 Aug 1;54(3):387–392. doi: 10.1002/1097-0142(19840801)54:3<387::aid-cncr2820540303>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  33. Silverberg E. Cancer statistics, 1985. CA Cancer J Clin. 1985 Jan-Feb;35(1):19–35. doi: 10.3322/canjclin.35.1.19. [DOI] [PubMed] [Google Scholar]
  34. Stagg R. J., Lewis B. J., Friedman M. A., Ignoffo R. J., Hohn D. C. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Ann Intern Med. 1984 May;100(5):736–743. doi: 10.7326/0003-4819-100-5-736. [DOI] [PubMed] [Google Scholar]
  35. Vyas G. N., Blum H. E. Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med. 1984 May;140(5):754–762. [PMC free article] [PubMed] [Google Scholar]
  36. Wellwood J. M., Cady B., Oberfield R. A. Treatment of primary liver cancer: response to regional chemotherapy. Clin Oncol. 1979 Mar;5(1):25–31. [PubMed] [Google Scholar]
  37. al-Sarraf M., Go T. S., Kithier K., Vaitkevicius V. K. Proceedings: Primary liver cancer. A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases. Cancer. 1974 Feb;33(2):574–582. doi: 10.1002/1097-0142(197402)33:2<574::aid-cncr2820330237>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES